Headache & Migraine Competitive Grant Program
The Headache & Migraine Competitive Grant Program stands at the forefront of advancing headache medicine by funding groundbreaking quality improvement initiatives. This highly competitive grant program, offered through the collaboration between the American Headache Society and Pfizer, supports projects that have the potential to reshape the field by creating widely applicable tools and driving measurable improvements in patient care. The program is designed to run three grant opportunities with award dates set between 2025 – 2026 with final grant recipient’s projects concluding at the end of 2028.
Migraine & Women's Health
Migraine is a prevalent and debilitating neurological disease that disproportionately affects women, impacting quality of life, productivity, and overall health. Recognizing the need for innovative solutions and enhanced care, Pfizer and the American Headache Society (AHS) are collaborating to offer a new grant opportunity inviting proposals for collaborative quality improvement and research projects focused on migraine and women's health.
View the RFP
Key Dates
- Request for Proposals posted: March 9, 2026
- Letter of Intent deadline: May 5, 2026
- Anticipated invitation to submit full proposal: June 30, 2026
- Invited full proposal deadline: August 28, 2026
- Anticipated award notification date: October 30, 2026
- Anticipated award start date: December 2026 or after
IMPORTANT: Only accepted LOIs will be invited to submit full proposals.
Approximate Funding Range and Project Length
Individual projects requesting up to $200,000 total over two (2) years will be considered. Proposals with smaller budgets are encouraged to apply.
Adult Population
Seeking projects that drive meaningful impact in headache care through advancements in safety, clinical effectiveness, timely diagnosis, and equitable, patient-centered treatment. Submissions should feature bold, practical solutions in primary care and non-headache specialty settings, supporting adult populations with scalable, real-world innovations.
The deadline for submitting a Letter of Intent for this grant opportunity has passed. If you submitted, please stay tuned in mid-May for whether your project has been invited to submit a full proposal.
View the RFP
Key Dates:
- Request for Proposals posted: December 3, 2025
- Letter of Intent deadline: February 25, 2026
- Anticipated invitation to submit full proposal: May 13, 2026
- Invited full proposal deadline: July 8, 2026
- Anticipated award notification date: September 30, 2026
- Anticipated award start date: December 1, 2026
IMPORTANT: Only accepted LOIs will be invited to submit full proposals.
Approximate Funding Range and Project Length
Individual projects requesting up to $250,000 total over two (2) years will be considered. Proposals with smaller budgets are encouraged to apply.
Quality Improvement Projects Addressing Critical Gaps in Headache Medicine
The first iteration of the Headache & Migraine Competitive Grant Program launched in May 2024 and awarded $1.24M to six projects seeking to uncover findings and build tools to improve access to high-quality, patient-centered headache medicine care.
Grant Recipients
We are proud to recognize the 2024 grant recipients, whose exceptional work exemplifies innovation, leadership, and a commitment to elevating headache and migraine treatment. Their projects represent the future of quality improvement in healthcare. Discover their impactful work below.
View the Press ReleaseChia-Chun Chiang, MD
Mayo Clinic
An Agentic Artificial Intelligence System for Efficiently Collecting and Summarizing Headache Information, Diagnosing Headache Types, and Optimizing Clinical Workflows
Jelena Pavlovic, MD, PhD
Montefiore Medical Center
Migraine and Perimenstrual Migraine Attacks in the Emergency Department: Improving Recognition and Ensuring Better Outcomes
Richelle deMayo, MD
Connecticut Children's Medical Center Foundation
HeadWay: Charting Coordination & Continuity Across the Transition from Adolescent-to-Adult Headache Care
Hannah Shapiro, MD
University of California San Francisco
Empowering Children and Adolescents Undergoing Needle-based Procedures for Headache Treatment through Implementation of a “Headache Procedure Comfort Menu”: a Novel Clinical Tool
Sinifunanya Nwaobi, MD, PhD
University of California, Los Angeles
Effectiveness of a School-based Interventional Migraine Program in Under-resourced Schools
Winnie Lau, MD
University of North Carolina
Reducing Emergency Department Length of Stay and Specialty Consultation Wait Times for Patients with Headache
